A Clinical Study to Explore CT1195E in Patients With Relapsed/Refractory B-Cell Neoplasms

Phase 1 Not yet recruiting 30 enrolled Institute of Hematology & Blood Diseases Hospital, China

NaSingle-groupOpen-labelTreatment

Summary

A Clinical Study to Explore the Safety, Efficacy and Cellular Metabolic Kinetics of CT1195E CAR-T Cells Injection in Patients with Relapsed/Refractory B-Cell Neoplasms

Timeline

Start: 2025-11-30
Primary completion: 2027-12-30
Completion: 2028-06-30

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	CT1195E	Cell therapy	—	—

A Clinical Study to Explore CT1195E in Patients With Relapsed/Refractory B-Cell Neoplasms

Summary

Timeline

Drugs

Indications